Biotech Snap logo
Biotech Snap
Subscribe
  • Biotech Snap
  • Archive
  • Page 0

Latest news

Renasant Bio launches with $54.5M to tackle rare kidney disease
15 hours ago

Renasant Bio launches with $54.5M to tackle rare kidney disease

Joachim Eeckhout
AbbVie pays $700 million upfront for a trispecific antibody from Ichnos Glenmark Innovation
Jul 10, 2025

AbbVie pays $700 million upfront for a trispecific antibody from Ichnos Glenmark Innovation

Joachim Eeckhout
Actithera lands $75.5M to chase next-gen cancer radiopharma
Jul 10, 2025

Actithera lands $75.5M to chase next-gen cancer radiopharma

Joachim Eeckhout
Merck bets $10B on COPD breakthrough with Verona Pharma buyout
Jul 09, 2025

Merck bets $10B on COPD breakthrough with Verona Pharma buyout

Joachim Eeckhout
Concentra snaps up troubled Cargo Therapeutics in latest biotech acquisition
Jul 09, 2025

Concentra snaps up troubled Cargo Therapeutics in latest biotech acquisition

Joachim Eeckhout
ProKidney’s cell therapy shows promise in chronic kidney disease trial
Jul 09, 2025

ProKidney’s cell therapy shows promise in chronic kidney disease trial

Joachim Eeckhout
Cogent challenges Blueprint Medicines’ Ayvakit with strong trial data for rare immune disease
Jul 08, 2025

Cogent challenges Blueprint Medicines’ Ayvakit with strong trial data for rare immune disease

Joachim Eeckhout
Early trial data backs AstraZeneca's $1B bet on EsoBiotec’s CAR-T therapy
Jul 08, 2025

Early trial data backs AstraZeneca's $1B bet on EsoBiotec’s CAR-T therapy

Joachim Eeckhout
Boston biotech industry is under pressure due to a funding drought and Trump's policy
Jul 07, 2025

Boston biotech industry is under pressure due to a funding drought and Trump's policy

Joachim Eeckhout
MaaT Pharma partners with Clinigen to launch Europe’s first microbiome therapy for aGvHD
Jul 04, 2025

MaaT Pharma partners with Clinigen to launch Europe’s first microbiome therapy for aGvHD

Joachim Eeckhout
Vyne's BET inhibitor ends psoriasis trial after FDA hold
Jul 03, 2025

Vyne's BET inhibitor ends psoriasis trial after FDA hold

Joachim Eeckhout
Biokin scores phase 3 win for BMS backed bispecific ADC
Jul 03, 2025

Biokin scores phase 3 win for BMS backed bispecific ADC

Joachim Eeckhout
FirstBack
123
Next Last
A daily 5-min biotech briefing

Biotech Snap

A daily 5-min biotech briefing

Home

Posts

© 2025 Biotech Snap.

Privacy policy

Terms of use

Powered by beehiiv